Free Trial
LON:UPR

Uniphar (UPR) Share Price, News & Analysis

Uniphar logo
GBX 169 0.00 (0.00%)
(As of 12/24/2024 ET)

About Uniphar Stock (LON:UPR)

Key Stats

Today's Range
166
170.53
50-Day Range
166
212
52-Week Range
166
256
Volume
1,725 shs
Average Volume
34,640 shs
Market Capitalization
£461.40 million
P/E Ratio
1,207.14
Dividend Yield
1.18%
Price Target
GBX 310
Consensus Rating
Buy

Company Overview

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Uniphar Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
25th Percentile Overall Score

UPR MarketRank™: 

Uniphar scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Uniphar has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Uniphar has received no research coverage in the past 90 days.

  • Read more about Uniphar's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Uniphar is 1,207.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 113.24.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Uniphar is 1,207.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 87.85.

  • Price to Book Value per Share Ratio

    Uniphar has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for UPR.
  • Dividend Yield

    Uniphar has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Uniphar does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Uniphar is 1,428.57%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Uniphar's dividend.
  • Short Interest

    There is no current short interest data available for UPR.
  • News Sentiment

    Uniphar has a news sentiment score of -1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Uniphar this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Uniphar insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.07% of the stock of Uniphar is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    45.25% of the stock of Uniphar is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Uniphar's insider trading history.
Receive UPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter.

UPR Stock News Headlines

Uniphar plc (UPR.IR)
Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Uniphar PLC UPR
Uniphar Plc Share Price (UPR.IE)
Uniphar plc (UPR.L)
See More Headlines

UPR Stock Analysis - Frequently Asked Questions

Uniphar's stock was trading at GBX 224 at the start of the year. Since then, UPR stock has decreased by 24.6% and is now trading at GBX 169.
View the best growth stocks for 2024 here
.

Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Uniphar investors own include IXICO (IXI) and ANGLE (AGL).

Company Calendar

Ex-Dividend for 10/4 Dividend
9/12/2024
Dividend Payable
10/04/2024
Today
12/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 310
High Stock Price Target
GBX 310
Low Stock Price Target
GBX 310
Potential Upside/Downside
+83.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£45.17 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.68 billion
Cash Flow
GBX 16.96 per share
Book Value
GBX 128 per share

Miscellaneous

Free Float
N/A
Market Cap
£461.40 million
Optionable
Not Optionable
Beta
0.75
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (LON:UPR) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners